Faculty profile

Vasundara Venkateswaran

ResearcherSurgeryUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Vasundara Venkateswaran

Researcher

Surgery

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2025.
Principal investigator on 2 research grants (2 CIHR), most recently in 2013.
Supervised 1 trainee who won CIHR awards, most recently in 2010.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Castrate Resistant Prostate Cancer Docetaxel Hyperinsulinemia Insulin/Igf Signaling Ionizing Radiation Metformin Obesity Prostate Cancer

Latest papers

The impact of topical tranexamic acid on drain duration and seroma volume in axillary lymph node dissection for breast cancer: A randomized controlled trial.
World journal of surgery · 2025
Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
The Prostate · 2019 · senior author
Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci.
The Prostate · 2019 · senior author

All 31 publications

Latest funding

Metformin: A radio- and chemo- sensitizer in prostate cancer
CIHR · 2013 · Nominated PI
$50,000
Utilizing metformin to enhance the efficacy of androgen deprivation therapy in prostate cancer
CIHR · 2010 · Nominated PI
$92,605
Examining Novel Biomarkers to Understand the Link Between Exercise, Lifestyle and Prostate Cancer
CIHR · 2010 · Supervisor
$17,500

All 3 grants and awards

31 publications.

The impact of topical tranexamic acid on drain duration and seroma volume in axillary lymph node dissection for breast cancer: A randomized controlled trial.

Garona J, Venkateswaran V, Alonso DF

World journal of surgery2025

DOI: 10.1002/wjs.12442 PMID: 39625391

Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.

Roberto D, Klotz LH, Venkateswaran V

The Prostate2019Senior author

DOI: 10.1002/pros.23720 PMID: 30242861

Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci.

Roberto D, Selvarajah S, Park PC, Berman D, Venkateswaran V

The Prostate2019Senior author

DOI: 10.1002/pros.23903 PMID: 31503357

Combining Desmopressin and Docetaxel for the Treatment of Castration-Resistant Prostate Cancer in an Orthotopic Model.

Bass R, Roberto D, Wang DZ, Cantu FP, Mohamadi RM, Kelley SO, Klotz L, Venkateswaran V

Anticancer research2019Senior author

DOI: 10.21873/anticanres.13086 PMID: 30591447

Total energy expenditure and vigorous-intensity physical activity are associated with reduced odds of reclassification among men on active surveillance.

Guy DE, Vandersluis A, Klotz LH, Fleshner N, Kiss A, Parker C, Venkateswaran V

Prostate cancer and prostatic diseases2018Senior author

DOI: 10.1038/s41391-017-0010-0 PMID: 29242596

Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance.

Zhao F, Olkhov-Mitsel E, van der Kwast T, Sykes J, Zdravic D, Venkateswaran V, Zlotta AR, Loblaw A, Fleshner NE, Klotz L, Vesprini D, Bapat B

The Journal of urology2017

DOI: 10.1016/j.juro.2016.08.081 PMID: 27545574

Evaluating Metformin as a Potential Chemosensitizing Agent when Combined with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Cells.

Mayer MJ, Klotz LH, Venkateswaran V

Anticancer research2017Senior author

DOI: 10.21873/anticanres.12117 PMID: 29187435

The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer.

Mayer MJ, Klotz LH, Venkateswaran V

The Journal of urology2017Senior author

DOI: 10.1016/j.juro.2016.10.069 PMID: 27984108

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M

Seminars in cancer biology2015

DOI: 10.1016/j.semcancer.2015.09.007 PMID: 26590477

Cancer prevention and therapy through the modulation of the tumor microenvironment.

Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, Crawford S, Fujii H, Georgakilas AG, Guha G, Halicka D, Helferich WG, Heneberg P, Honoki K, Keith WN, Kerkar SP, Mohammed SI, Niccolai E, Nowsheen S, Vasantha Rupasinghe HP, Samadi A, Singh N, Talib WH, Venkateswaran V, Whelan RL, Yang X, Felsher DW

Seminars in cancer biology2015

DOI: 10.1016/j.semcancer.2015.02.007 PMID: 25865775

Something wrong or missing on this profile? Suggest a correction

Vasundara Venkateswaran

Research

Latest papers

Latest funding

The impact of topical tranexamic acid on drain duration and seroma volume in axillary lymph node dissection for breast cancer: A randomized controlled trial.

Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.

Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci.

Combining Desmopressin and Docetaxel for the Treatment of Castration-Resistant Prostate Cancer in an Orthotopic Model.

Total energy expenditure and vigorous-intensity physical activity are associated with reduced odds of reclassification among men on active surveillance.

Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance.

Evaluating Metformin as a Potential Chemosensitizing Agent when Combined with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Cells.

The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Cancer prevention and therapy through the modulation of the tumor microenvironment.

Metformin: A radio- and chemo- sensitizer in prostate cancer

Utilizing metformin to enhance the efficacy of androgen deprivation therapy in prostate cancer

Examining Novel Biomarkers to Understand the Link Between Exercise, Lifestyle and Prostate Cancer

Frequent collaborators

Neil Fleshner

Arun Seth

Bharati Bapat

Andrew Loblaw

Laurent Briollais

David Berman

Sender Herschorn

Jenna Sykes

Adam Shlien

Satya Prakash

Ricardo Rendon

Jehonathan Pinthus

Jack Gauldie

Ronan Foley

David Malkin

Katherine Siminovitch

Christopher Maxwell